Pan Y - Search Results

1

Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion.

Pan Y, Liu X, Zhang W, Wang W, Wang H, Luo L, Jia K, Shao C, Mao S, Qiu T, Ni J, Yu J, Wang L, Chen B, Xiong A, Gao G, Chen X, Wu F, Zhou C, Wu C, Ren S. Pan Y, et al. Lung Cancer. 2023 Jul;181:107233. doi: 10.1016/j.lungcan.2023.107233. Epub 2023 May 10. Lung Cancer. 2023. PMID: 37201296

2

Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC.

Yang S, Mao S, Li X, Zhao C, Liu Q, Yu X, Wang Y, Liu Y, Pan Y, Wang C, Gao G, Li W, Xiong A, Chen B, Sun H, He Y, Wu F, Chen X, Su C, Ren S, Zhou C. Yang S, et al. Among authors: pan y. Lung Cancer. 2020 Jan;139:133-139. doi: 10.1016/j.lungcan.2019.11.018. Epub 2019 Nov 24. Lung Cancer. 2020. PMID: 31786475 Clinical Trial.

3

Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma.

Liu Y, Dong Z, Jiang T, Hou L, Wu F, Gao G, He Y, Zhao J, Li X, Zhao C, Zhang W, Tian Q, Pan Y, Wang Y, Yang S, Wu C, Ren S, Zhou C, Zhang J, Hirsch FR. Liu Y, et al. Among authors: pan y. Clin Lung Cancer. 2018 Jul;19(4):e421-e430. doi: 10.1016/j.cllc.2018.02.008. Epub 2018 Mar 31. Clin Lung Cancer. 2018. PMID: 29609906

4

Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer.

Pan Y, Gao G, Chen X, Tian Q, Wu F, Liu Q, Wang Y, Jiang T, Liu Y, Li X, Yang S, Xu C, Su C, Zhou F, Ren S, Zhou C. Pan Y, et al. Thorac Cancer. 2019 Apr;10(4):686-694. doi: 10.1111/1759-7714.12986. Epub 2019 Feb 22. Thorac Cancer. 2019. PMID: 30793872 Free PMC article.

5

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations.

Yang S, Wang Y, Zhao C, Li X, Liu Q, Mao S, Liu Y, Yu X, Wang W, Tian Q, Pan Y, Xiong A, Chen B, Gao G, Li W, He Y, Wu F, Chen X, Su C, Ren S, Zhou C. Yang S, et al. Among authors: pan y. Transl Lung Cancer Res. 2021 Feb;10(2):753-765. doi: 10.21037/tlcr-20-559. Transl Lung Cancer Res. 2021. PMID: 33718019 Free PMC article.

6

High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.

Liu Y, Wang W, Wu F, Gao G, Xu J, Li X, Zhao C, Yang S, Mao S, Pan Y, Jia K, Shao C, Chen B, Ren S, Zhou C. Liu Y, et al. Among authors: pan y. Transl Lung Cancer Res. 2021 Mar;10(3):1512-1524. doi: 10.21037/tlcr-20-1290. Transl Lung Cancer Res. 2021. PMID: 33889526 Free PMC article.

7

Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Yu X, Dong Z, Wang W, Mao S, Pan Y, Liu Y, Yang S, Chen B, Wang C, Li X, Zhao C, Jia K, Shao C, Wu C, Ren S, Zhou C. Yu X, et al. Among authors: pan y. Cancer Manag Res. 2021 May 17;13:3981-3990. doi: 10.2147/CMAR.S302545. eCollection 2021. Cancer Manag Res. 2021. PMID: 34040439 Free PMC article.

8

Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.

Shao C, Yang M, Pan Y, Xie D, Chen B, Ren S, Zhou C. Shao C, et al. Among authors: pan y. Front Immunol. 2021 Aug 3;12:696749. doi: 10.3389/fimmu.2021.696749. eCollection 2021. Front Immunol. 2021. PMID: 34413851 Free PMC article.

9

CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer.

Liu Q, Qiao M, Lohinai Z, Mao S, Pan Y, Wang Y, Yang S, Zhou F, Jiang T, Yi X, Ren S, Zhou C, Hirsch FR. Liu Q, et al. Among authors: pan y. Lung Cancer. 2021 Dec;162:194-202. doi: 10.1016/j.lungcan.2021.11.003. Epub 2021 Nov 11. Lung Cancer. 2021. PMID: 34823893

10

Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion.

Pan Y, Xiao W, Ye F, Wang H, Shen Y, Yu X, Han X, Chu Q, Zhou C, Zhang Z, Ren S. Pan Y, et al. Ann Transl Med. 2021 Jun;9(12):1014. doi: 10.21037/atm-21-2769. Ann Transl Med. 2021. PMID: 34277814 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,501 results

Search Page